Showing results (101-110 of 123) with videos related to
Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.American Journal of Clinical Oncology|December 18, 1998
A phase II trial and pharmacokinetic analysis of 96-hour infusional paclitaxel in patients with metastatic colorectal cancerK Huang, D J Vaughn, L M Shaw, et al.Oncology|April 15, 2000
A phase II study of gemcitabine and 5-fluorouracil in metastatic pancreatic cancer: an Eastern Cooperative Oncology Group Study (E3296)J D Berlin, S Adak, D J Vaughn, et al.European Journal of Cancer Care|September 10, 2010
Sleep and daily functioning during androgen deprivation therapy for prostate cancerL J Hanisch, N S Gooneratne, K Soin, et al.Gastroenterology|October 26, 2001
Inflammatory bowel disease is not associated with an increased risk of lymphomaJ D Lewis, W B Bilker, C Brensinger, et al.JAMA|September 28, 1998
Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Human Heredity|November 26, 2002
Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4C M Zeigler-Johnson, A H Walker, B Mancke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 1998
Calculated prostate cancer volume greater than 4.0 cm3 identifies patients with localized prostate cancer who have a poor prognosis following radical prostatectomy or external-beam radiation therapyA V D'Amico, R Whittington, S B Malkowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancerA V D'Amico, R Whittington, S B Malkowicz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Eastern Cooperative Oncology Group Phase I trial of protracted venous infusion fluorouracil plus weekly gemcitabine with concurrent radiation therapy in patients with locally advanced pancreas cancer: a regimen with unexpected early toxicityM S Talamonti, P J Catalano, D J Vaughn, et al.Pageof 13